Cognitive deterioration among bipolar disorder patients infected by Toxoplasma gondii is correlated to interleukin 6 levels

Journal of Affective Disorders

Volumn 179, Issue , 2015, Pages 161-166

  Hamdani, Nora ^a,b,c   Daban Huard, Claire ^a,b,c   Lajnef, Mohamed ^a,b,c   Gadel, Rémi ^a,b,c   Le Corvoisier, Philippe ^f   Delavest, Marine ^d,e   Carde, Soufiane ^a,b,c,d   Lépine, Jean Pierre ^c,e   Jamain, Stéphane ^c,e   Houenou, Josselin ^a,b,c,d   Galeh, Bijan ^f   Richard, Jean Romain ^a,c   Aoki, Masayuki ^a,c   Charron, Dominique ^a,c   Krishnamoorthy, Rajagopal ^g   Yolken, Robert ^h   Dickerson, Faith ^h   Tamouza, Ryad ^c,i   Leboyer, Marion ^a,b,c  

^a INSERM   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c FONDATION FONDAMENTAL   (France)

^d NeuroSpin   (France)

^e HÔPITAL LARIBOISIÈRE   (France)

^f UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^g INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ Stanley Research Program   (United States)

Author keywords

Bipolar disorder; Cognitive deterioration; IL 6; T. gondii

Indexed keywords

INTERLEUKIN 6; MESSENGER RNA;

ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; EPISODIC MEMORY; FEMALE; GENE EXPRESSION; HUMAN; INFLAMMATION; MALE; MENTAL DETERIORATION; MENTAL PATIENT; PREDICTIVE VALUE; PRIORITY JOURNAL; SEROLOGY; TOXOPLASMA GONDII; TOXOPLASMOSIS; VERBAL BEHAVIOR; VERBAL MEMORY; WECHSLER INTELLIGENCE SCALE; WORKING MEMORY; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; COGNITIVE DEFECT; COMPLICATION; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PSYCHOLOGY;

ADULT; BIPOLAR DISORDER; CASE-CONTROL STUDIES; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; TOXOPLASMOSIS;

EID: 84926621730     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2015.03.038     Document Type: Article

References (78)

1. C. Alvarado-Esquivel Seroepidemiology of infection with Toxoplasma gondii in workers occupationally exposed to water, sewage, and soil in Durango, Mexico J. Parasitol. 96 5 2010 847 850
2. C. Alvarado-Esquivel Seroepidemiology of Toxoplasma gondii infection in general population in a northern Mexican city J. Parasitol. 97 1 2011 40 43
3. M. Aoki Decreased pro-inflammatory cytokines and increased CCR7 expression on T-lymphocyte subsets are predictive of response to extracorporeal photopheresis in patients with GvHD Br. J. Psychiatry 133 2011 429 435
4. I. Arias Infectious agents associated with schizophrenia: a meta-analysis Schizophr. Res. 136 1-3 2012 128 136
5. T.A. Arling Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders 197 12 2009 905 908
6. P. Athilingam Elevated levels of interleukin 6 and C-reactive protein associated with cognitive impairment in heart failure Congest. Heart Fail. 19 2 2013 92 98
7. M.M. Behrens, S.S. Ali, and L.L. Dugan Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia J. Neurosci. 28 51 2008 13957 13966
8. I.J. Blader, I.D. Manger, and J.C. Boothroyd Microarray analysis reveals previously unknown changes in Toxoplasma gondii-infected human cells J. Biol. Chem. 276 26 2001 24223 24231
9. R.M. Bilder Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration Schizophr. Bull. 18 3 1992 437 448
10. C.V. Bourne Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis Acta Psychiatr. Scand. 128 3 2013 149 162
11. P. Brambilla, M. Bellani, and M. Isola Increased M1/decreased M2 signature and signs of Th1/Th2 shift in chronic patients with bipolar disorder, but not in those with schizophrenia Transl. Psychiatry 4 7 2014 e406
12. E. Brietzke, and F. Kapczinski TNF-alpha as a molecular target in bipolar disorder Prog. Neuropsychopharmacol. Biol. Psychiatry 32 6 2008 1355 1361
13. E. Brietzke Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder J. Affect. Disord. 116 3 2009 214 217
14. E. Brietzke Therapeutic potential of interleukin-6 antagonism in bipolar disorder Med. Hypotheses 76 1 2011 21 23
15. A.S. Brown Prenatal exposure to maternal infection and executive dysfunction in adult schizophrenia Am. J. Psychiatry 166 6 2009 683 690
16. A.S. Brown Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism Dev. Neurobiol. 72 10 2012 1272 1276
17. K.E. Burdick COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance Bipolar Disord. 9 4 2007 370 376
18. K.E. Burdick Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction J. Clin. Psychiatry 73 1 2012 103 112
19. K.E. Burdick Empirical evidence for discrete neurocognitive subgroups in bipolar disorder: clinical implications Psychol. Med. 44 14 2014 3083 3096
20. V.B. Carruthers, and Y. Suzuki Effects of Toxoplasma gondii infection on the brain Schizophr. Bull. 33 3 2007 745 751 Epub 2007 Feb 23. Review
21. D.C. Delis, J.H. Kramer, E. Kaplan, and B.A. Ober California Verbal Learning Test: Adult Version 1987 The Psychological Corporation San Antonio, TX
22. F. Dickerson Antibodies to Toxoplasma gondii and cognitive functioning in schizophrenia, bipolar disorder, and nonpsychiatric controls J. Nerv. Ment. Dis. 202 8 2014 589 593
23. F. Dickerson Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia Arch. Gen. Psychiatry 60 5 2003 466 472
24. F. Dickerson Association between cognitive functioning, exposure to Herpes SimplexVirus type 1, and the COMT Val158Met genetic polymorphism in adults without a psychiatric disorder Brain Behav. Immun. 22 7 2008 1103 1107
25. F. Dickerson Additive effects of elevated C-reactive protein and exposure to Herpes Simplex Virus type 1 on cognitive impairment in individuals with schizophrenia Schizophr. Res. 134 1 2012 83 88
26. J. Flegr Effects of Toxoplasma on human behavior Schizophr. Bull. 33 3 2007 757 760
27. B.I. Goldstein Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature J. Clin. Psychiatry 70 8 2009 1078 1090
28. G.M. Goodwin Cognitive impairment in bipolar disorder: neurodevelopment or neurodegeneration? An ECNP expert meeting report Eur. Neuropsychopharmacol. 18 11 2011 787 793
29. E. Gyori, and B.A. Hyma Fatal automobile crash caused by cerebral toxoplasmosis Am. J. Forensic Med. Pathol. 19 2 1998 178 180
30. J. Flegr Increased risk of traffic accidents in subjects with latent toxoplasmosis: a retrospective case-control study BMC Infect. Dis. 2 2002 11
31. J. Flegr Increased incidence of traffic accidents in Toxoplasma-infected military drivers and protective effect RhD molecule revealed by a large-scale prospective cohort study BMC Infect. Dis. 26 9 2009 72
32. T. Fukunaga Unusual calcification in brain suspected to be caused by toxoplasmosis: a report of an autopsy case Nihon Hoigaku Zasshi 43 1 1989 52 57
33. C. Goeldner Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target Neuropharmacology 64 2013 337 346
34. R. Grassi-Oliveira Interleukin-6 and verbal memory in recurrent major depressive disorder Neuro Endocrinol. Lett. 32 4 2011 540 544
35. N. Hamdani Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample J. Affect. Disord. 148 2-3 2013 444 448
36. J. Havlícek Decrease of psychomotor performance in subjects with latent 'asymptomatic' toxoplasmosis Parasitology 122 Pt 5 2001 515 520
37. T. Hellvin Neurocognitive functioning in patients recently diagnosed with bipolar disorder Bipolar Disord. 14 3 2012 227 238
38. W.M. Hutchinson Behavioural abnormalities in Toxoplasma-infected mice Ann. Trop. Med. Parasitol. 74 3 1980 337 345
39. G. Kannan Toxoplasma gondii strain-dependent effects on mouse behaviour Folia Parasitol. (Praha) 57 2 2010 151 155
40. G. Kannan, and M.V. Pletnikov Toxoplasma gondii and cognitive deficits in schizophrenia: an animal model perspective Schizophr. Bull. 38 6 2012 1155 1161
41. F. Kapczinski Allostatic load in bipolar disorder: implications for pathophysiology and treatment Neurosci. Biobehav. Rev. 32 4 2008 675 692
42. F. Kapczinski The potential use of biomarkers as an adjunctive tool for staging bipolar disorder Prog. Neuropsychopharmacol. Biol. Psychiatry. 33 8 2009 1366 1371
43. T.M. Karplus, and K.G. Saag Nonsteroidal anti-inflammatory drugs and cognitive function: do they have a beneficial or deleterious effect? Drug Saf. 19 6 1998 427 433
44. B. Kocazeybek Higher prevalence of toxoplasmosis in victims of traffic accidents suggest increased risk of traffic accident in Toxoplasma-infected inhabitants of Istanbul and its suburbs Forensic Sci. Int. 187 1-3 2009 103 108
45. M. Leboyer, and D.J. Kupfer Bipolar disorder: new perspectives in care and prevention health J. Clin. Psychiatry 71 12 2010 1689 1695
46. H. Ledford Mental-health guide accused of overreach Nature 479 7371 2011 14
47. R.E. Marioni Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study 59 3 2010 710 713
48. A. Martinez-Aran Functional outcome in bipolar disorder: the role of clinical and cognitive factors Bipolar Disord. 9 2007 103 113
49. J. Matowicka-Karna, V. Dymicka-Piekarska, and H. Kemona Does Toxoplasma gondii infection affect the levels of IgE and cytokines (IL-5, IL-6, IL-10, IL-12, and TNF-alpha) Clin. Dev. Immunol. 2009 2009 374696
50. M.L. Monje, H. Toda, and T.D. Palmer Inflammatory blockade restores adult hippocampal neurogenesis Science 302 5651 2003 1760 1765
51. Montgomery, S.A., Asberg, M., A new depression scale designed to be sensitive to change. Br. J. Psychiatry 1979.
52. J.G. Montoya, and O. Liesenfeld Toxoplasmosis Lancet 363 9425 2004 1965 1976
53. N. Müller The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine Mol. Psychiatry 11 7 2006 680 684
54. K. Munkholm State-related alterations of gene expression in bipolar disorder: a systematic review Bipolar Disord. 14 7 2012 684 696
55. K.S. Na, H.Y. Jung, and Y.K. Kim The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia Prog. Neuropsychopharmacol. Biol. Psychiatry 48 2014 277 286
56. K. Nakano Dopamine induces IL-6-dependent IL-17 production via D1-like receptor on CD4 naive T cells and D1-like receptor antagonist SCH-23390 inhibits cartilage destruction in a human rheumatoid arthritis/SCID mouse chimera model J. Immunol. 186 6 2011 3745 3752
57. H. Nelson The National Adult Reading Test NFER-Nelson 1982 Windsor UK
58. J.I. Nurnberger Jr, M.C. Blehar, and C.A. Kaufmann Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH genetics initiative Arch. Gen. Psychiatry 51 11 1994 849 859
59. B.D. Pearce, D. Kruszon-Moran, and J.L. Jones The relationship between Toxoplasma gondii infection and mood disorders in the third National Health and Nutrition Survey Biol. Psychiatry 72 4 2012 290 295
60. J.M. Petitto Relationship between the development of autoimmunity and sensorimotor gating in MRL-lpr mice with reduced IL-2 production Neurosci. Lett. 328 3 2002 304 308
61. G. Piekarski, H.M. Zippelius, and P.A. Witting Effects of a latent Toxoplasma infection on the learning ability in white laboratory rats and mice (author's transl) Z. Parasitenkd. 57 1 1978 1 15
62. M.H. Rapaport, L. Guylai, and P. Whybrow Immune parameters in rapid cycling bipolar patients before and after lithium treatment J. Psychiatr. Res. 33 4 1999 335 340
63. A.R. Rosa Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder Br. J. Haematol. 154 3 2007 409 413
64. H. Sakurai Dopamine D2 receptor occupancy and cognition in schizophrenia: analysis of the CATIE data Schizophr. Bull. 39 3 2013 564 574
65. P. Stolk Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder Prostaglandins Leukot Essent Fat. Acids 82 1 2010 9 14
66. Y. Tedla Serum antibodies to Toxoplasma gondii and Herpesvidae family viruses in individuals with schizophrenia and bipolar disorder: a case-control study Ethiop. Med. J. 49 3 2011 211 220
67. E.F. Torrey, and R.H. Yolken Toxoplasma gondii and schizophrenia Emerg. Infect. Dis. 9 11 2003 1375 1380
68. E.F. Torrey, and R.H. Yolken The schizophrenia-rheumatoid arthritis connection: infectious, immune, or both? Brain Behav. Immun. 15 4 2001 401 410
69. S.Y. Tsai Activation of indices of cell-mediated immunity in bipolar mania Biol. Psychiatry 45 8 1999 989 994
70. J.D. Weaver Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging Neurology. 59 3 2002 371 378
71. D. Wechsler WAIS-III: Manual for the Wechsler Adults Intelligence Scale third edition 1997 The Psychological Corporation. French Translation San Antonio, TX 2000
72. D. Wechsler WAIS-III: Manuel de l'Echelle d'Intelligence de Wechsler pour Adultes 3rd edition Additif 2000 Les Editions du Centre de Psychologie Appliquée Paris
73. C.B. Wright Interleukin-6 is associated with cognitive function: the Northern Manhattan Study J. Stroke Cerebrovasc. Dis. 15 1 2006 34 38
74. K. Yereli, I.C. Balcioʇlu, and A. Ozbilgin Is Toxoplasma gondii a potential risk for traffic accidents in Turkey? Forensic Sci. Int. 163 1-2 2006 34 37
75. R.H. Yolken, and E.F. Torrey Viruses, schizophrenia, and bipolar disorder Clin. Microbiol. Rev. 8 1 1995 131 145
76. R.H. Yolken Antibodies to Toxoplasma gondii in individuals with first-episodeschizophrenia Clin. Infect. Dis. 32 5 2001 842 844
77. R.H. Yolken, F.B. Dickerson, and F.E. Torrey Toxoplasma and schizophrenia Parasite Immunol. 31 11 2009 706 715
78. R.C. Young A rating scale for mania: reliability, validity and sensitivity Br. J. Psychiatry 133 1978 429 435